Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10213 |
| Vaccine Name | GSK HSV Vaccine |
| Disease Name | Genital Herpes |
| Disease Classification | Cutaneous |
| Virus Name | Herpes simplex virus |
| Nucleic Acid Content | double stranded DNA |
| Vaccine Type | RNA based vaccine |
| Vaccine Status | Phase 1 |
| Manufacturer | GlaxoSmithKline |
| Year of Manufacturing | 2021 |
| Manufacturing Country | UK |
| Age | 18 - 40 years |
| Dosage | 2 doses at interval of 2 months |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Herpes simplex virus 2 glycoprotein D (gD-2) |
| Description | mRNA based vaccine |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates |
| Additional Links | https://www.precisionvaccinations.com/vaccines/hsv-2-vaccine-gsk4108771a#:~:text=The%20herpes%20simplex%20virus%20type,genetic%20code%20of%20a%20virus. |